MigreLief-Now for Migraine and Headache Sufferers, 60 Vegetarian Capsules
- Fast-acting nutritional support for migraine or headache sufferers - MigreLief-NOW is a drug-free nutritional supplement designed to promote neurological and overall comfort on an as-needed basis. Effective for both adults and children age 2 or older.
- Don't let a migraine or headache ruin your day! This fast-acting supplement contains ingredients clinically proven to be of benefit for migraine and headache sufferers. May keep on hand at all times, and take as-needed, when you need help fast. Non-drowsy formula, perfect for busy days.
- Trusted formula makes a difference. MigreLief has been changing the lives of hundreds of thousands of migraine sufferers worldwide for over two decades. MigreLief-NOW does not cause rebound headaches, and may be combined with any MigreLief daily formula.
- Proven ingredients. Formulated by migraine supplement pioneer, based on scientific evidence, Akeso's Chief Scientific Officer Curt Hendrix was the first to discover the unique combination of effective ingredients for migraine sufferers, and has received two United States patents with a 3rd patent pending.
- Made in the USA, safe & effective - MigreLief-NOW is drug-free, non-prescription, vegetarian and non-GMO. Does not contain butterbur, wheat, gluten, salt, soy, milk or dairy, nuts, corn, caffeine, artificial flavorings or preservatives. Ingredients are tested by independent 3rd party laboratories. Manufactured in certified facilities in the United States.
Indications
Migraine and headache pain. Fast-acting, as-needed nutritional support.
Ingredients
Magnesium (Citrate and Oxide) 180mg, Puracol Feverfew (whole leaf & extract) ** 50mg, Cerevasc Ginger (root powder & extract) *** 500mg, Aflapin Boswellia Serrata (extract) **** 100mg. (*Daily Value Not Established) **Puracol is a proprietary combination of whole leaf feverfew that contains a broad spectrum of naturally occurring phytochemicals and a unique feverfew extract. *** Cerevasc Ginger is a proprietary combination of ginger rhizome powder and standardized ginger extract. ****Aflapin is a registered trademark Laila Nutraceuticals. International patents pending. Other Ingredients: Powdered Cellulose, grape seed extract, silicon dioxide, magnesium stearate (vegetable grade), vegetable capsule, hydroxypropyl methylcellulose, titanium dioxide.
Directions
Age 14-Adult: Take 3-4 capsules with food. May repeat dose in 2 hours. Do not exceed 8 capsules in a 24 hour period, or 4 if combining with a MigreLief daily formula. Age 9-13: 1-2 capsules with food. May repeat dose in 2 hours. Do not exceed 4 capsules in a 24 hour period, or 2 if combining with a MigreLief daily formula. Age 2-8: 1 capsule with food. May repeat dose in 2 hours. Do not exceed 2 capsules in a 24 hour period.
Legal Disclaimer
Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Safety Warning: Not for use during pregnancy, lactation, or by children under age 2. Please consult a physician before taking this product. Please do not take this product if you are allergic to any of the ingredients. Ingredients: Magnesium (Citrate and Oxide) 180mg, Puracol Feverfew (whole leaf & extract) ** 50mg, Cerevasc Ginger (root powder & extract) *** 500mg, Aflapin Boswellia Serrata (extract) **** 100mg. (*Daily Value Not Established) **Puracol is a proprietary combination of whole leaf feverfew that contains a broad spectrum of naturally occurring phytochemicals and a unique feverfew extract. *** Cerevasc Ginger is a proprietary combination of ginger rhizome powder and standardized ginger extract. ****Aflapin is a registered trademark Laila Nutraceuticals. International patents pending. Other Ingredients: Powdered Cellulose, grape seed extract, silicon dioxide, magnesium stearate (vegetable grade), vegetable capsule, hydroxypropyl methylcellulose, titanium dioxide. All MigreLief dietary supplements were formulated by migraine supplement pioneer, scientist Curt Hendrix, M.S., C.C.N., C.N.S., Chief Scientific Officer of Akeso Health Sciences. Curt was the principal investigator of multiple NIH (National Institutes of Health) studies. MigreLief was granted two United States patents, #6068999 and #6500450, with a third patent pending.
Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.